Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids

Inclusion Criteria: * Subject is able to read, understand and sign an IC form * 22 or older * Self-assessed symptoms are consistent with dry eye (SPEED score ≥ 10) * Signs of MGD, as detected in biomicroscopy * Fitzpatrick skin type I-V * Subject is willing to comply with all study procedures, including return to the clinic 1 day and 1 week after the first and only treatment within the scope of the study Exclusion Criteria: * • Fitzpatrick skin type VI * Ocular surgery or eyelid surgery, within 3 months prior to screening * Recent ocular trauma, within 3 months prior to screening * Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area * Severe active allergies, or other severe uncontrolled eye disorders affecting the ocular surface * Uncontrolled infections or uncontrolled immunosuppressive diseases * Subjects with ocular infections requiring the use of antibiotic treatment, within 3 months prior to screening * Legally blind in either eye * Ocular surface abnormality that may compromise corneal integrity in either eye (e.g., keratoconus, recurrent corneal erosion, corneal epithelial defect, Grade 3 corneal fluorescein staining, map dot fingerprint dystrophy, prior chemical burn) * Eyelid abnormalities that affect lid function in either eye, including: entropion, ectropion, tumor, blepharospasm, lagophthalmos, severe trichiasis, and severe ptosis * Prior history of cold sores or rashes in the perioral area or in the planned treatment area that could be stimulated by light at a wavelength of 560 nm to 1200 nm, including: Herpes simplex 1 \& 2, Systemic Lupus erythematosus, and porphyria * Within 3 months prior to screening, use of photosensitive medication and/or herbs that may cause sensitivity to 560-1200 nm light exposure, including: Isotretinoin, Tetracycline, Doxycycline, and St. John's Wort * Over exposure to sun, within 4 weeks prior to screening * Moderate to severely compromised corneal health as assessed by corneal fluorescein staining * Trans-illumination defects * Anisocoria or pupil deformation * Anterior chamber inflammation * Media opacities (cataract, posterior capsule opacification, corneal edema, etc.) that preclude clear visualization of the anterior segment and retina * Any condition revealed whereby the investigator deems the subject inappropriate for this study